The Recall Desk

FDA (Drugs) recall action 87268

Wilshire Pharmaceuticals Inc recalled 2 products on 2021-02-24

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2021-02-24
Critical
0
Units
38,040

Why these products were recalled

Failed Dissolution Specifications

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

States named across these recalls

1–2 of 2

  • ModerateFDA (Drugs)··2021-02-24

    Wilshire Pharmaceuticals Recalls Meclizine HCl Tablets for Dissolution Failures

    Wilshire Pharmaceuticals is recalling 3,592 bottles of Meclizine HCl 25 mg tablets because they failed dissolution specifications. The affected product was distributed in Florida and Texas.

    Product
    Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-133-01
    Category
    Distribution
    2 states
  • ModerateFDA (Drugs)··2021-02-24

    Wilshire Pharmaceuticals Recalls Meclizine HCl Tablets for Dissolution Failures

    Wilshire Pharmaceuticals is recalling 2,112 bottles of Meclizine HCl 12.5 mg tablets found in Florida and Texas because they failed dissolution specifications.

    Product
    Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-129-01
    Category
    Distribution
    2 states